PHILADELPHIA (June 17, 2024) – Ten startups from the US and UK have been selected to participate in the fifth cohort of the Science Center’s Capital Readiness Program, sponsored by Cozen O’Connor. The founders will be in Philadelphia June 24-28 for the five-day bootcamp designed to give health tech startups a competitive edge as they embark on their first institutional capital raise.
Since the program launched in 2023, 18 alumni companies of the Capital Readiness Program have raised $23.8M.
“The Capital Readiness Program magnifies startup vulnerabilities, so founders are more prepared when approaching investors in a risk averse funding climate. We’re eager to welcome this latest cohort of exceptional health tech companies to Philadelphia to help position them for success,” says Tiffany Wilson, president & CEO of the Science Center.
June 2024 cohort:
- Calla Lily Clinical Care (London, UK) - Revolutionary & convenient drug delivery platform for fertility/pregnancy, a healthy vaginal microbiome and other gynecological conditions.
- CygnusMed Inc (Akron, OH) – By providing continuous blood pressure measurement, Cygnus’s device aims to eliminate the second arterial access in all endovascular intervention.
- Dama Health (London, UK) – Dama Health is a healthtech company bringing precision medicine to women's reproductive health, using the power of real-world data and genetics to enable personalized prescribing and care.
- DriQ Health (Philadelphia, PA) – DriQ Health has created the world's first battery free disposable smart diaper for senior living leveraging advanced AI analytics with remote patient monitoring technology.
- Four-Forty Imaging (Boston, MA) – Four-Forty Imaging is developing medical imaging technology to enable the visualization of dermal collagen, offering a significant advancement for physicians in skin cancer treatment and skin assessment.
- Hibiscus Health (New York, NY) – Hibiscus Health is a pioneering digital health platform leveraging AI-driven facial biometric scans for early detection and proactive management of metabolic conditions like diabetes and hypertension, aiming to reduce healthcare costs for employers.
- InnoTech Precision Medicine, Inc (Natick, MA) – Advanced cancer detection through multimodal biomarker analysis for better health outcomes.
- Kauna (Cambridge, MA) – A healthcare startup that helps nephrology practices deliver value-based care to people with chronic kidney disease.
- ThirdLaw Molecular LLC (Blue Bell, PA) – ThirdLaw Molecular uses screening and AI to develop therapeutics based on Spiroligomer(TM) molecules; they are an unexplored chemical space that combines the good drug properties of small molecules with the selectivity of antibodies.
- Voythos (Houston, TX) – Voythos is building multimodal machine learning models to predict life-threatening complications in aortic disease, prompting cardiovascular surgeons to intervene sooner, saving lives and limbs.
Designed specifically for health tech startups embarking on their first institutional round of financing, the Capital Readiness Program gives founders an opportunity to interface directly with investors and due diligence partners, engage in startup stress test scenarios, and finalize their deal rooms.
Capital Readiness participants work hand-in-hand with Investors-in-Residence sourced from the Science Center’s national network representing $2.5B in venture capital. The 2:1 ratio of startups to investors gives founders meaningful opportunities for engagement with and feedback from industry-relevant check-writing investors.
Investors-in-Residence for the June 2024 cohort:
- Kim Frazier, Executive Director, EC Angels (Dayton, OH)
- Julien Pham, Founder and Managing Partner, 3CC | Third Culture Capital (Boston, MA)
- Dan Sands, Managing Partner, Factor 7 Medical (Dayton, OH)
- Anish Srivastava, Managing Partner, Telosity Ventures (Redwood City, CA)
- Vanessa Villaverde, Senior Program Investor, California Health Care Foundation (Oakland, CA)
The next Capital Readiness cohort will run December 9-13, 2024. Interested in applying? Submit your information to our Capital Readiness Program interest form
The Capital Readiness Program is funded in part by the FY24 federal budget package that passed in March.
ABOUT THE SCIENCE CENTER
The Science Center is Philadelphia’s premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Established in 1963, the nonprofit has been recognized by The Brookings Institution as a best-in-class investor, mentor, and economic development partner for young technology companies. Working alongside industry partners and leading research and academic institutions across the globe, the Science Center has supported hundreds of early-stage companies that have a combined $7.8B annual economic impact on Greater Philadelphia. Today, the organization advances healthcare innovation from idea to the marketplace through startup support services and building inclusive STEM pathways for Philadelphia youth and adults. For more information, visit sciencecenter.org or follow us @UCScienceCenter.
